270. Tuberculous and Nontuberculous Mycobacteria
Saturday, October 10, 2015: 2:00 PM-3:30 PM
Room: 31--ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • discuss updates on the clinical management of tuberculous meningitis and nontubercular mycobacterial disease
  • assess how recent research on the pathophysiology of mycobacterial diseases can impact medical management
  • explain host-directed therapies and personalized medicine in the context of mycobacterial disease
  • describe mycobacterial evasion strategies that have thwarted classical vaccine strategies and how these might be overcome

Target Audience: Scientists, Vaccinologists, Researchers, Public health practitioners, Pharmacists, Nurses, Microbiologists, Members-in-training, Lab personnel, Investigators, Infectious diseases physicians, Infectious diseases pediatricians, Infection preventionists, Hospital epidemiologists, HIV specialists, HIV clinicians, Healthcare workers, Fellows, Epidemiologists, Clinicians, Academicians

Tracks: Pediatric ID, Investigative ID, HIV-STD-TB, Global ID, Adult ID, Trainee

Moderators:  Joel Ernst, MD, FIDSA, New York University School of Medicine and Lalita Ramakrishnan, MD, PhD, University of Cambridge

CME Credits: Maximum of 1.5 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of pharmacy CE

ACPE Number: 0221-9999-15-202-L01-P


J. Ernst, None

L. Ramakrishnan, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.